Edition:
United States

Aakash B

Strong surgical instrument sales fuel Medtronic's upbeat forecast

May 23 2019

Medtronic Plc reported quarterly profit ahead of estimates on strong demand for its surgical instruments and forecast better-than-expected 2020 earnings on Thursday, sending shares of the medical device maker up nearly 3%.

Mylan gives no clear view on strategic options, shares plunge 17 percent

May 07 2019

Drugmaker Mylan NV on Tuesday reported lower-than-expected quarterly revenue and failed to provide greater clarity on a potential revamp of the company's strategy, sending its shares down 17 percent to a more than six-and-a-half year low.

Bausch Health's lotion for plaque psoriasis wins FDA approval

Apr 25 2019

The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc's topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company.

Walgreens cuts 2019 profit forecast, hit by lower drug prices

Apr 02 2019

Walgreens Boots Alliance Inc shares fell 13 percent on Tuesday after the company cut its 2019 earnings forecast and reported a disappointing quarterly profit in the face of stubbornly low generic drug prices in a crowded market.

Jazz Pharma's sleep disorder treatment gets FDA nod

Mar 20 2019

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday.

Jazz Pharma's sleep disorder treatment gets FDA nod

Mar 20 2019

March 20 The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday.

Health insurer Humana's full-year profit forecasts disappoints

Feb 06 2019

Humana Inc's full-year profit forecast came in shy of analysts' estimates on Wednesday as its Medicare Prescription drug plans remained under pressure and said it expects 2019 margins in the fast-growing business to fall short of its own targets.

Amgen's postmenopausal osteoporosis drug wins FDA panel backing

Jan 16 2019

An advisory panel to the U.S. Food and Drug Administration said on Wednesday that benefits of Amgen Inc's osteoporosis treatment for postmenopausal women at high risk for fracture outweighed its risks and overwhelmingly voted for the drug's approval.

Medtronic sets rosy outlook on strong cardiac, surgical product sales

Nov 20 2018

Medical device maker Medtronic Plc on Tuesday beat analysts' profit estimates for the second quarter and boosted its annual revenue growth outlook, driven by robust sales at its cardiac and surgical product units, sending its shares up 3 percent.

World News